联系电话：010-
【】&&&&【】&&&&
网友评论 已有[0]人评论
用户名: 密码:
评论只代表网友观点，不代表本站观点。
请输入验证码： <font color="#FF
?&<font color=#-20)
?&<font color=#-19)
?&<font color=#-15)
?&<font color=#-8)
?&<font color=#-25)
?&<font color=#-9)
?&<font color=#-29)
?&<font color=#-29)
?&<font color=#-1)
?&<font color=#-28)
?&<font color=#-7)
?&<font color=#-3)
?&<font color=#-1)
?&<font color=#-1)
?&<font color=#-20)
?&<font color=#-19)
Copyright(C)
中国生物器材网 电话：021-产品中心 Menu
ROCHE(罗氏)产品
今迈生物-您的生命科学研究助手!
产品名称：
LightCycler 480 High Resolution Melting Master
今迈编号：
5×100反应(20 μl)
原厂货号：
LightCycler 480 High Resolution Melting Master分子生物学
本公司长期备有常用ROCHE产品，让您的实验无需等待，节省您的宝贵时间。
更多ROCHE现货 见下表：
FS Universal SYBR Green Master(Rox)
SYBR定量PCR试剂（用于ABI仪器）
LightCycler Capillaries (20 ?l)
5x 96根/盒
In Situ Cell Death fluorescein
1 kit (50 tests)FR
TULEL凋亡试剂盒（绿色荧光）
In Situ Cell Death POD
1 kit (50 tests)
凋亡试剂盒
TRIPURE ISOLATION REAGENT 200
PVDF Western Blotting Membrane
1 roll (30 cm x 3.00 m)
In Situ Cell Death TMR
1 kit (50 tests)
TULEL凋亡试剂盒（红色荧光）
Anti-digoxigenin AP-conjungate
150 U (200 ?l)
AP-标记抗地高辛抗体
Cell Proliferation ELISA,BrdU
1 kit (1,000 tests)
BRDU增殖检测试剂盒
cOmplete,EDTA-free,EASYpack,20
20 tablets (in foil blisters) CR
蛋白酶抑制剂
PhosStop, 20 Tablets
20 tablets (each tablet for 10 ml)
磷酸酶抑制剂
X-tremeGENE HP DNA Transf. Reag.
##1.0 ml*FR
Collagenase D, 500mg
LightCycler 480 Multiwell Plate 384
5 x 10 块板 (含封板膜)
cOmplete ULTRA Tablets, Mini, EDTA-free, EASYpack
30 tablets
蛋白酶抑制剂
DIG Wash and Block Buffer Set
1 set (30 blots)
Cell Proliferation Reagent WST
25 ml (2,500 tests) FR
WST增殖检测试剂盒
DIG High Prime Lab/Detection K
1 kit (12 labeling reactions and 24 detection reactions)FR
地高辛标记/检测试剂盒I
cOmplete ULTRA Tablets, Mini, EASYpack
30 tablets
蛋白酶抑制剂
cOmplete,Mini,EDTA-free,EASYpa
30 tablets (in foil blisters)
蛋白酶抑制剂
LightCycler 480 SYBR Green I Master, 10 x 5 ml
10×500反应(20 μl) FR
SYBR定量PCR试剂（用于ROCHE仪器）
LightCycler 480 Multiwell Plate 96
5 x 10 块板 (含封板膜)RT
DIG Easy-Hyb
地高辛杂交液
PhosStop, 10 Tablets
10 tablets (each tablet for 10 ml)
磷酸酶抑制剂
Transcriptor cDNA Synth. Kit 1
1 kit (100 reactions)
反转录试剂盒
Nylon Membranes, 1 roll
1 roll (0.3 x 3 m) RT
Dispase II (neutral protease,
DIG RNA Labeling Mixture, 10x
40 ?l (20 reactions)
Anti-HA High Affinity (3F10),
cOmplete,EASYpack,20 Tab.
20 tablets (in foil blisters)
蛋白酶抑制剂
Blocking Reagent
DIG Easy Hyb Granules
granules for 6 x 100 ml
X-tremeGENE 9 DNA Transf. Reag.
##1.0 ml CR
Cell Death Detection ELISA^PLU
1 kit (96 tests)
PCR Dig Probe Synthesis 1pc
1 kit (25 reactions)
Protein A-Agarose
Pronase,Lyo.
5 g (non-sterile)*CR
Transcriptor cDNA Synth. Kit 2
1 kit (200 reactions)
反转录试剂盒
HP PCR Template Preparation Ki
1 kit (100 purifications)
X-tremeGENE HP DNA Transf. Reag. 1.0 ml
Cytotoxicity Det.Kit PLUS (LDH
1 kit (400 tests in 96 wells)FR
LDH细胞毒检测试剂盒
LightCycler 480 High Resolution Melting Master
5×100反应(20 μl)
DIG High Prime Lab./Det.Kit II
1 kit (12 labeling reactions and 24 detection reactions)
地高辛标记/检测试剂盒II
Protein G-Agarose
Genopure Plasmid Maxi Kit
1 kit (for up to 10 preparations)
LightCycler 480 SYBR Green I Master, 5 x 1 ml
5×100反应(20 μl)FR
CDP-Star, ready-to-use
Expand HiFi PCR Sys., 500 u
500 U (2 x 250 U)
DNase I, Grade II
Genopure Plasmid Midi Kit
1 kit (for up to 20 preparations)*RT
Hybridization Bags
Glycogen , MB Grade
20 mg (1 ml)*FR
&【】【】【】
地址：广州市天河区东圃园丁路13号园丁商务中心238室 | 电话：020- | E-mail: |
广州沃威生物科技有限公司 版权所有& High-Resolution Melting Analysis Using the Roche LightCycler Instrument for Rapid and Reliable Methylation...
Press release BoxID 358522
, 08.07.2010)
Promoter hypermethylation is a frequent mechanism for the repression of gene transcription in cancer and is regarded as one of the hallmarks of cancer. Analysis of DNA methylation is a promising tool for early cancer detection, risk assessment, and response to therapy. In a recent study (1), quantitative highresolution melting analysis (HRM) with the Roche (SIX: RO, ROG; OTCQX: RHHBY) LightCycler Instrument was used for promoter methylation for analysis of formalinfixed paraffinembedded (FFPE) tissues. Since FFPE tissue samples are the largest source of material from normal controls and diseased tissues, their use is of inestimable value for research. Methodical evaluations are of high importance for demonstrating robustness and sensitivity of the assay, thus facilitating its establishment as a research tool and possibly a future routine test.
The aim of the study was to establish and evaluate HRM assays for detection of promoter methylation on archival FFPE tissues from individuals with colorectal cancer. As proof of the principle, the researchers demonstrated the applicability of HRM for detection of promoter methylation using assays for O6methylguanine-DNA methyltransferase (MGMT), adenomatous polyposis coli (APC), glutathione Stransferase P1 (GSTP1), and phosphatase and tension homolog deleted on chromosome 10 (PTEN) promoters in methylated DNA dilution matrix. In a second step, HRM assays for MGMT and APC were tested on DNA isolated from fresh and FFPE human cancer cell lines. These established MGMT and APC HRM assays were analyzed using archival FFPE colorectal tumor specimens. Methylated DNA levels as low as 1% were reproducibly detected in a background of unmethylated DNA. For certain applications, such as detection of rare events or risk stratification of individuals based on methylation status of specific markers, high sensitivity of the assay is important. This sensitive assay can be adapted and used to detect low amounts of methylated cells within a tumor, or even to detect low numbers of tumor cells in the background of nontumor cells in lymph nodes and other organs.
The most popular approaches for DNA methylation detection rely on the treatment of genomic DNA with sodium bisulfite, which converts cytosine into uracil while leaving 5methyl cytosine unmodified. This modification results in a sequence difference allowing for identification of methyl cytosines in a subsequent PCR amplification. The most precise methylation profiling can be achieved by bisulfite sequencing, which allows identification of single methyl cytosines. Several simpler PCRbased methods, which are especially important for small scale research labs, have also been developed. One of these newer and easier methods is highresolution melting analysis (HRM), based on the &melting& properties of DNA in solution. The principle of this method is that bisulfitetreated DNA templates with different contents of methyl cytosine can be distinguished by melting analysis based on differences in melting temperatures. HRM is a relatively simple and costeffective method, since it does not require expensive probes and reference gene assays for normalization. With HRM, all CpGs within the amplicon are analyzed, enabling the assay to distinguish heterogeneous from homogeneous methylation by the shape of the melting curve. This ability can be of importance, because methylation patterns at promoter CpG islands are typically not homogeneous.
(1) Roche Applied Science Cancer Research Application Note No. 3: M. Malic, M. Pichler, E. Heitzer, J. Strutz, N. Dandachi (2009) High quality assessment of DNA methylation in archival tissues from patients with colorectal cancer using quantitative highresolution melting analysis, .
Share this press release:
About Roche Diagnostics Deutschland GmbH
Headquartered in Basel, Switzerland, Roche is a leader in researchfocused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in invitro diagnostics and tissuebased cancer diagnostics, and is a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: .
07.06.2016 -
31.05.2016 -
25.05.2016 -
Claudia Fuchs
Assistant to Dr. Jochen Strack, Head of Global Finance RAS
Dr. Burkhard Ziebolz
Roche Applied Science
Head Global Communication
Roche Diagnostics Deutschland GmbH
Sandhofer Str. 116
D-68305 Mannheim
The PresseBox site relays on the functionality of JavaScript. This seems not to be available in your browser. We appologize if parts of the website may not be full accessible with the lack of JavaScript.}